Free Trial
→ URGENT: This Altcoin Opportunity Won’t Wait – Act Now (From Crypto Swap Profits) (Ad) Free MPSYF Stock Alerts

MorphoSys (MPSYF) SEC Filings & 10K Form

MorphoSys logo
$73.27 0.00 (0.00%)
(As of 11/21/2024)
Compare

Recent MorphoSys SEC Filings

Export to Excel
DateFilerForm TypeView
10/17/2024
3:54 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 15-12G
10/04/2024
3:21 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:24 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:27 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:30 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:33 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:36 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:18 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form S-8 POS
10/04/2024
3:16 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form POSASR
08/27/2024
9:14 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
08/13/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
08/07/2024
3:51 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC 14D9/A
08/07/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
08/05/2024
7:14 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
08/01/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/31/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/30/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/29/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/25/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/25/2024
3:05 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
07/18/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/18/2024
10:25 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2024
3:20 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
07/05/2024
5:48 AM		MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC 14D9
07/05/2024
5:02 AM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T
07/02/2024
9:18 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
06/21/2024
9:07 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
3:41 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
3:33 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC14D9C
06/20/2024
2:38 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-C
06/17/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
06/10/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC 13D/A
06/10/2024
11:06 AM		GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC 13G/A
06/10/2024
10:01 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2024
3:36 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/05/2024
9:22 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)

You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.

Click Here to get the full details about Crypto’s Hidden Gem
06/04/2024
9:17 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2024
9:17 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
9:17 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
9:16 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
9:13 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
1:19 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC 14D9/A
05/23/2024
9:11 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
8:04 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
9:07 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/17/2024
9:15 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
3:43 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC 14D9/A
05/16/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/16/2024
9:11 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
9:09 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
9:27 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2024
9:19 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2024
9:31 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2024
9:08 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
3:45 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/07/2024
9:24 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/06/2024
9:07 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/03/2024
9:29 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/02/2024
9:43 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
9:07 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
7:57 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
3:15 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
9:17 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2024
9:11 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/25/2024
9:38 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
10:03 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2024
9:14 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
9:32 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
9:17 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/18/2024
1:33 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC 13D
04/18/2024
9:13 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2024
3:49 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC 14D9/A
04/17/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/16/2024
4:07 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/16/2024
9:12 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2024
2:44 PM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/12/2024
9:54 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
10:57 AM		MorphoSys AG (Subject)
MorphoSys (Subject)
Form SC 14D9
04/11/2024
5:01 AM		MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T
04/09/2024
9:07 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
9:19 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
9:15 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.
04/02/2024
9:08 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2024
12:16 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2024
10:15 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2024
10:37 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
10:17 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
5:47 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2024
10:27 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
3:12 PM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
10:13 AM		MorphoSys AG (Filer)
MorphoSys (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (OTCMKTS:MPSYF) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners
This Crypto Is Set to Explode in December
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
Could This Tiny Device Help You Make an Extra $30k a Year?
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...
Brownstone Research | Sponsored
WARNING: “Buffett Indicator” flashing for first time in 50 years
Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...
Behind the Markets | Sponsored
Your bank is lying to you.
You might think you have your money in a high-yield savings account, but do you really? The national average A...
MyBankTracker | Sponsored
Rare "crisis signal" triggers for third time in U.S. market
A rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...
Stansberry Research | Sponsored
AI breakthrough about to upend industry
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...
Porter & Company | Sponsored
HOTTEST TRADER IN AMERICA 🔥🔥🔥
Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...
Timothy Sykes | Sponsored
Buffett's Oil Bet + This 22% Dividend Play
Warren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...
Investors Alley | Sponsored